Integrated gut virome and bacteriome dynamics in COVID-19 patients/Experiment 2

From BugSigDB


Reviewed Marked as Reviewed by Atrayees on 2023-7-10

Curated date: 2021/07/02

Curator: Claregrieve1

Revision editor(s): Claregrieve1, WikiWorks

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
COVID-19 2019 novel coronavirus,2019 novel coronavirus infection,2019-nCoV,2019-nCoV infection,beta-CoV,beta-CoVs,betacoronavirus,coronavirus disease 2019,SARS-coronavirus 2,SARS-CoV-2,severe acute respiratory syndrome coronavirus 2,severe acute respiratory syndrome coronavirus 2 infectious disease,β-coronavirus,β-CoV,β-CoVs,COVID-19,cOVID-19
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Antibiotic-naive COVID-19 patients
Group 1 name Corresponds to the case (exposed) group for case-control studies
Antibiotic-treated COVID-19 patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients with COVID-19 treated with antibiotics
Group 0 sample size Number of subjects in the control (unexposed) group
8
Group 1 sample size Number of subjects in the case (exposed) group
5

Lab analysis

Sequencing type
WMS
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
Not specified
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Statistical test
Linear Regression
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by Atrayees on 2023-7-10

Curated date: 2021/07/02

Curator: Claregrieve1

Revision editor(s): Claregrieve1

Source: Figure 3g

Description: Differential abundance of microbial taxa between antibiotic-naive COVID-19 patients and antibiotic-treated COVID-19 patients

Abundance in Group 1: increased abundance in Antibiotic-treated COVID-19 patients

NCBI Quality ControlLinks
Veillonella parvula
unclassified Coprobacillus
Thomasclavelia ramosa

Revision editor(s): Claregrieve1

Signature 2

Reviewed Marked as Reviewed by Atrayees on 2023-7-10

Curated date: 2021/07/02

Curator: Claregrieve1

Revision editor(s): Claregrieve1

Source: Figure 3g

Description: Differential abundance of microbial taxa between antibiotic-naive COVID-19 patients and antibiotic-treated COVID-19 patients

Abundance in Group 1: decreased abundance in Antibiotic-treated COVID-19 patients

NCBI Quality ControlLinks
Subdoligranulum sp.
Roseburia inulinivorans
Roseburia hominis
Parasutterella excrementihominis
Lachnospiraceae bacterium 2 1 46FAA
Faecalibacterium prausnitzii
Dorea formicigenerans
Coprococcus catus
Collinsella aerofaciens
Phocaeicola vulgatus

Revision editor(s): Claregrieve1